192 related articles for article (PubMed ID: 32119879)
21. Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with Grade Group 5 prostate cancer.
Oufattole J; Dey T; D'Amico AV; van Leenders GJLH; Acosta AM
Histopathology; 2023 Jun; 82(7):1089-1097. PubMed ID: 36939057
[TBL] [Abstract][Full Text] [Related]
22. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
Czaja RC; Tarima S; Wu R; Palagnmonthip W; Iczkowski KA
Ann Diagn Pathol; 2021 Jun; 52():151725. PubMed ID: 33610958
[TBL] [Abstract][Full Text] [Related]
23. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.
Ronen S; Abbott DW; Kravtsov O; Abdelkader A; Xu Y; Banerjee A; Iczkowski KA
Hum Pathol; 2017 Jul; 65():85-91. PubMed ID: 28504208
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of architectural subtypes of Gleason grade 4 prostate cancer in radical prostatectomy: A semiquantitative method of evaluation.
da Paz AR; Billis A; Freitas LLL; Costa LBE; Barreto IS; Magna LA; Matheus WE; Ferreira U
Ann Diagn Pathol; 2021 Feb; 50():151678. PubMed ID: 33341702
[TBL] [Abstract][Full Text] [Related]
25. Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer.
Greenland NY; Cowan JE; Stohr BA; Simko JP; Carroll PR; Chan E
Histopathology; 2024 Mar; 84(4):614-623. PubMed ID: 38012532
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
J Urol; 2017 Apr; 197(4):1060-1067. PubMed ID: 27847296
[TBL] [Abstract][Full Text] [Related]
27. Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.
Diolombi ML; Epstein JI
BJU Int; 2017 Jun; 119(6):872-878. PubMed ID: 27496532
[TBL] [Abstract][Full Text] [Related]
28. Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores.
Okubo Y; Sato S; Hasegawa C; Koizumi M; Suzuki T; Yamamoto Y; Yoshioka E; Ono K; Washimi K; Yokose T; Kishida T; Miyagi Y
Hum Pathol; 2023 May; 135():99-107. PubMed ID: 36738975
[TBL] [Abstract][Full Text] [Related]
29. Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
Kweldam CF; Kümmerlin IP; Nieboer D; Steyerberg EW; Bangma CH; Incrocci L; van der Kwast TH; Roobol MJ; van Leenders GJ
Mod Pathol; 2017 Aug; 30(8):1126-1132. PubMed ID: 28530220
[TBL] [Abstract][Full Text] [Related]
30. Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome.
van der Slot MA; Hollemans E; den Bakker MA; Hoedemaeker R; Kliffen M; Budel LM; Goemaere NNT; van Leenders GJLH
Virchows Arch; 2021 Feb; 478(2):249-256. PubMed ID: 32815034
[TBL] [Abstract][Full Text] [Related]
31. Primary Gleason pattern in biopsy Gleason score 7 is predictive of adverse histopathological features and biochemical failure following radical prostatectomy.
Berg KD; Røder MA; Brasso K; Vainer B; Iversen P
Scand J Urol; 2014 Apr; 48(2):168-76. PubMed ID: 23889119
[TBL] [Abstract][Full Text] [Related]
32. A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.
Hesterberg AB; Rios BL; Wolf EM; Tubbs C; Wong HY; Schaffer KR; Lotan TL; Giannico GA; Gordetsky JB; Hurley PJ
J Pathol Clin Res; 2021 May; 7(3):271-286. PubMed ID: 33600062
[TBL] [Abstract][Full Text] [Related]
33. Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
Grober ED; Tsihlias J; Jewett MA; Sweet JM; Evans AJ; Trachtenberg J; Robinette M; Nam RK
Can J Urol; 2004 Feb; 11(1):2157-62. PubMed ID: 15003158
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of concordance of Gleason score between prostate biopsy and radical prostatectomy.
Mansouri N; Msakni I; Gargouri F; Khiari R; Bouziani A; Laabidi B
Tunis Med; 2018 Jul; 96(7):430-436. PubMed ID: 30430487
[TBL] [Abstract][Full Text] [Related]
35. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
[TBL] [Abstract][Full Text] [Related]
36. Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.
Leo P; Chandramouli S; Farré X; Elliott R; Janowczyk A; Bera K; Fu P; Janaki N; El-Fahmawi A; Shahait M; Kim J; Lee D; Yamoah K; Rebbeck TR; Khani F; Robinson BD; Shih NNC; Feldman M; Gupta S; McKenney J; Lal P; Madabhushi A
Eur Urol Focus; 2021 Jul; 7(4):722-732. PubMed ID: 33941504
[TBL] [Abstract][Full Text] [Related]
37. Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma.
Dong F; Yang P; Wang C; Wu S; Xiao Y; McDougal WS; Young RH; Wu CL
Am J Surg Pathol; 2013 Dec; 37(12):1855-61. PubMed ID: 24145642
[TBL] [Abstract][Full Text] [Related]
38. Significance of the cribriform pattern in prostatic adenocarcinomas.
Sarbay BC; Kir G; Topal CS; Gumus E
Pathol Res Pract; 2014 Sep; 210(9):554-7. PubMed ID: 24831265
[TBL] [Abstract][Full Text] [Related]
39. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
Fine SW; Epstein JI
J Urol; 2008 Apr; 179(4):1335-8; discussion 1338-9. PubMed ID: 18289601
[TBL] [Abstract][Full Text] [Related]
40. Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.
Whittemore DE; Hick EJ; Carter MR; Moul JW; Miranda-Sousa AJ; Sexton WJ
J Urol; 2008 Feb; 179(2):516-22; discussion 522. PubMed ID: 18076949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
